ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) |
Apr. 01, 2021
USD ($)
shares
|
Jan. 22, 2021
item
|
Sep. 30, 2021
shares
|
---|---|---|---|
Business Acquisition [Line Items] | |||
Warrants to purchase shares of common stock | 1,561,373 | ||
Marpai Health | |||
Business Acquisition [Line Items] | |||
Options to purchase shares of common stock | 1,027,602 | ||
Warrants to purchase shares of common stock | 1,366,746 | ||
Conversion ratio | 1 | ||
Amount of convertible promissory notes exchanged for shares of common stock | 3,800,000 | ||
Convertible promissory notes acquired | $ | $ 2,198,459 | ||
Continental Benefits | |||
Business Acquisition [Line Items] | |||
Number of healthcare subsidiaries | item | 2 | ||
Minimum cash on hand required at the time of closing of Acquisition | $ | 4,762,000 | ||
Debt at the time of closing of Acquisition | $ | $ 0 |
X | ||||||||||
- Definition Represents the conversion ratio in business combination to exchange options and warrants. No definition available.
|
X | ||||||||||
- Definition Represents the amount of debt at the time of closing of Acquisition. No definition available.
|
X | ||||||||||
- Definition Represents the amount of minimum cash on hand required at the time of closing of Acquisition. No definition available.
|
X | ||||||||||
- Definition Represents the number of healthcare subsidiaries. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|